Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INNOVATE Corp. Director's Dealing 2014

Oct 30, 2014

34366_dirs_2014-10-30_8e44f926-7972-4e96-9e64-6ddfbdc680a1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HC2 Holdings, Inc. (HCHC)
CIK: 0001006837
Period of Report: 2014-10-28

Reporting Person: FALCONE PHILIP (Director, CEO, 10% Owner)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-10-28 Stock Option (right to buy) $4.05 A 234608 Acquired 2024-05-20 Common Stock (234608) Direct
2014-10-28 Stock Option (right to buy) $3.77 A 53963 Acquired 2024-05-20 Common Stock (53963) Direct
2014-10-28 Stock Option (right to buy) $3.98 A 6140 Acquired 2024-05-20 Common Stock (6140) Direct
2014-10-28 Stock Option (right to buy) $4.00 A 2394 Acquired 2024-05-20 Common Stock (2394) Direct
2014-10-28 Stock Option (right to buy) $4.04 A 33124 Acquired 2024-05-20 Common Stock (33124) Direct
2014-10-28 Stock Option (right to buy) $4.02 A 50247 Acquired 2024-05-20 Common Stock (50247) Direct
2014-10-28 Stock Option (right to buy) $4.03 A 52485 Acquired 2024-05-20 Common Stock (52485) Direct
2014-10-28 Stock Option (right to buy) $3.85 A 49372 Acquired 2024-05-20 Common Stock (49372) Direct
2014-10-28 Stock Option (right to buy) $3.99 A 280472 Acquired 2024-05-20 Common Stock (280472) Direct
2014-10-28 Stock Option (right to buy) $4.05 A 750000 Acquired 2024-05-20 Common Stock (750000) Direct
2014-10-28 Stock Option (right to buy) $4.00 A 2667 Acquired 2024-05-20 Common Stock (2667) Direct
2014-10-28 Stock Option (right to buy) $4.46 A 7786 Acquired 2024-05-20 Common Stock (7786) Direct
2014-10-28 Stock Option (right to buy) $4.36 A 258824 Acquired 2024-05-20 Common Stock (258824) Direct

Footnotes

F1: Reflects shares underlying an additional option (the "Option") to purchase shares of the common stock of HC2 Holdings, Inc. (the "Company") issued pursuant to an option agreement, originally dated as of May 21, 2014 and as reformed and clarified on October 26, 2014 (the "Option Agreement"), between the Company and Philip Falcone.

F2: The Option vests in three equal annual installments beginning on the date of issuance, subject to Mr. Falcone's continued employment with the Company on each vesting date, and will become immediately exercisable in the event of a Fundamental Change Transaction (as defined in the Option Agreement).

F3: The Option vests in three equal annual installments beginning on the date of issuance, subject to Mr. Falcone's continued employment with the Company on each vesting date, and will become immediately exercisable in the event of a Fundamental Change Transaction (as defined in the Option Agreement). The Option is also contingent on the conversion of the Company's Preferred Stock.